Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc. > Rumors CGC APHA round 2
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1223)
•••
Comment by ProfCorneliuson Oct 12, 2020 3:34pm
333 Views
Post# 31704742

RE:RE:Rumors CGC APHA round 2

RE:RE:Rumors CGC APHA round 2
Positivelive1 wrote: Why would APH merge with a company that can't turn a profit or produce winning brands?


How about receivng oodles of capital, via STZ, to conquer Europe with, unencumbered access, through CGC, to a ginormous US market that is about to open up soon if the Dems take the senate and presidency and the fact that Aphrias share price will rocket when CGC takes a majority stake while retaining Irwin Simon as CEO. Sounds good to me. Prof
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities